Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jan;39(1):77–80. doi: 10.1111/j.1365-2125.1995.tb04413.x

Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism.

Z Liu 1, O Mortimer 1, C A Smith 1, C R Wolf 1, A Rane 1
PMCID: PMC1364985  PMID: 7756104

Abstract

Ethylmorphine is metabolised by N-demethylation (to norethylmorphine) and by O-deethylation (to morphine). The O-deethylation reaction was previously shown in vivo to co-segregate with the O-demethylation of dextromethorphan indicating that ethylmorphine is a substrate of polymorphic cytochrome P450(CYP)2D6. To study further the features of ethylmorphine metabolism we investigated its N-demethylation and O-deethylation in human liver microsomes from eight extensive (EM) and one poor metaboliser (PM) of dextromethorphan. Whereas N-demethylation varied only two-fold there was a 4.3-fold variation in the O-deethylation of ethylmorphine, the lowest rate being observed in the PM. Quinidine, at a concentration of 1 microM, inhibited O-deethylation in microsomes from an EM, but was unable to do so in microsomes from the PM. The immunoidentified CYP2D6 and CYP3A4 correlated with the rates of O-deethylation (r = 0.972) and N-demethylation (r = 0.969), respectively. We conclude that the O-deethylation of ethylmorphine is catalysed by the CYP2D6 in human liver microsomes consistent with previous findings in healthy volunteers.

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen Z. R., Somogyi A. A., Bochner F. Polymorphic O-demethylation of codeine. Lancet. 1988 Oct 15;2(8616):914–915. doi: 10.1016/s0140-6736(88)92529-9. [DOI] [PubMed] [Google Scholar]
  2. Dayer P., Desmeules J., Leemann T., Striberni R. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI). Biochem Biophys Res Commun. 1988 Apr 15;152(1):411–416. doi: 10.1016/s0006-291x(88)80729-0. [DOI] [PubMed] [Google Scholar]
  3. Elshourbagy N. A., Guzelian P. S. Separation, purification, and characterization of a novel form of hepatic cytochrome P-450 from rats treated with pregnenolone-16 alpha-carbonitrile. J Biol Chem. 1980 Feb 25;255(4):1279–1285. [PubMed] [Google Scholar]
  4. Forrester L. M., Henderson C. J., Glancey M. J., Back D. J., Park B. K., Ball S. E., Kitteringham N. R., McLaren A. W., Miles J. S., Skett P. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J. 1992 Jan 15;281(Pt 2):359–368. doi: 10.1042/bj2810359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ladona M. G., Spalding D. J., Ekman L., Linström B., Rane A. Human fetal and adult liver metabolism of ethylmorphine. Relation to immunodetected cytochrome P-450 PCN and interactions with important fetal corticosteroids. Biochem Pharmacol. 1989 Oct 1;38(19):3147–3155. doi: 10.1016/0006-2952(89)90607-2. [DOI] [PubMed] [Google Scholar]
  6. Mortimer O., Persson K., Ladona M. G., Spalding D., Zanger U. M., Meyer U. A., Rane A. Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1. Clin Pharmacol Ther. 1990 Jan;47(1):27–35. doi: 10.1038/clpt.1990.4. [DOI] [PubMed] [Google Scholar]
  7. Rane A., Ask B. A conspicuous down-regulating effect of morphine on essential steroid hydroxylation reactions and certain drug N-demethylations. J Steroid Biochem Mol Biol. 1992 Jan;41(1):91–98. doi: 10.1016/0960-0760(92)90229-c. [DOI] [PubMed] [Google Scholar]
  8. Rane A., Modiri A. R., Gerdin E. Ethylmorphine O-deethylation cosegregates with the debrisoquin genetic metabolic polymorphism. Clin Pharmacol Ther. 1992 Sep;52(3):257–264. doi: 10.1038/clpt.1992.139. [DOI] [PubMed] [Google Scholar]
  9. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., Sturman S. G., Schapira A. H., Williams A. C., Maranganore D. M. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 1992 Jun 6;339(8806):1375–1377. doi: 10.1016/0140-6736(92)91196-f. [DOI] [PubMed] [Google Scholar]
  10. Xu B. Q., Bjørneboe A., Ripel A., Aasmundstad T. A., Christophersen A. S., Mørland J. Ethylmorphine metabolism in isolated rat hepatocytes. Pharmacol Toxicol. 1993 Jul;73(1):35–40. doi: 10.1111/j.1600-0773.1993.tb01954.x. [DOI] [PubMed] [Google Scholar]
  11. Yue Q. Y., Svensson J. O., Alm C., Sjöqvist F., Säwe J. Interindividual and interethnic differences in the demethylation and glucuronidation of codeine. Br J Clin Pharmacol. 1989 Dec;28(6):629–637. doi: 10.1111/j.1365-2125.1989.tb03555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES